More than seven million Americans are living with Alzheimer’s disease. Millions more are caring for family members and loved ones affected by the disease. By 2050, the number of Americans with the disease is projected to grow to nearly 13 million if no major breakthroughs change the disease’s course.

Americans across the country are united by the desire to end the burden of Alzheimer’s disease – neither the biology nor the impacts of Alzheimer’s are political; we are united in seeking prevention, treatment, and ultimately, a cure.

Continued progress toward treatments and a cure depends on stable research funding guided by scientific expertise and rigorous peer review. Protecting that process helps researchers pursue the discoveries that patients and families are counting on.

Every breakthrough begins with evidence-based science. A proposed policy from the Office of Management and Budget (OMB) would change how federal research grants are awarded and managed, weakening the role of independent scientific review and empowering political appointees to suspend or terminate research grants for any or no reason. The complex and intensive research needed to uncover treatments and a cure for Alzheimer’s disease is rendered infeasible without committed and stable funding guided by data and expertise. Cure Alzheimer’s Fund is a nonpartisan organization committed to accelerating progress toward preventing, slowing, and ultimately curing Alzheimer’s disease. We believe the research that patients and families are counting on must remain guided by scientific expertise, rigorous peer review, and evidence—not politics.

Take Action

Thanks to advocacy from people across the country, the Senate included a provision in a Continuing Resolution that would prevent the proposed OMB rule from taking effect until at least December 11. The House is expected to consider the measure when it returns later this month. This potential delay is an important step, but it is not a permanent solution. CureAlz believes the proposed rule should be voted down.

Now is an important time to contact your senators and representatives.

Ask them to:

• Support efforts to prevent the proposed OMB rule from taking effect.
• Protect research funding decisions based on scientific expertise and rigorous peer review.
• Support a stable research environment that accelerates discoveries for Alzheimer’s disease and other serious illnesses.

How to Contact Your Representatives:

1. Find your representatives’ contact information by visiting: https://www.congress.gov/members/find-your-member
2. Call and leave a message or send an email.

Sample message:

Personalizing your message with why Alzheimer’s disease research matters to you can make it even more meaningful.

Hello, my name is [Your Name], and I am a constituent from [City, State].

I’m contacting you because I support Alzheimer’s disease research. I respectfully ask you to support efforts to prevent the Office of Management and Budget’s proposed rule on Regulation for Federal Financial Assistance from taking effect.

Research funding decisions should continue to be guided by scientific expertise and rigorous peer review so that scientists can pursue the discoveries that bring us closer to preventing, slowing and reversing Alzheimer’s disease.

Thank you for your time and consideration.